Removal of Benign Skin Lesions, Keloid and Hypertrophic Scarring
- Referral form
Please note referrals will be returned to referrers unless the correct referral form is used
- The policy information for keloid and hypertrophic scarring
- Dermatology Life Quality Index
Leeds CCGs consider the removal of seborrheic keratosis, sebaceous cysts, naevi (moles) or skin tags and warts, keloid or hypertrophic scars cosmetic unless one of the following eligibility criteria are met:
- There is documented evidence of inflammation, e.g., purulence, edema, erythema over at least 3 months not responding to conservative treatment; AND the patient has a Dermatology Life Quality Index score of over 10.
- Due to its anatomic location, the lesion has been subject to recurrent trauma
- The lesion restricts vision or obstructs a body orifice
- Lesion appears to be dysplastic or malignant (due to coloration, change in appearance or size, etc., especially in a person with dysplastic nevus syndrome, history of melanoma, or family history of melanoma)
- Biopsy suggests or is indicative of pre malignancy (e.g., dysplasia) or malignancy.
- Keloid/hypertrophic scar is symptomatic – i.e. resulting in physical impairment due to contractures, tethering, severe pain/pruritus or recurrent breakdown. (please see the policy for keloid and hypertrophic scarring above for further information)
The removal of warts in non immuno-compromised patients is considered cosmetic and patients should be encouraged to seek self care.
Removal of Xanthelasma is considered cosmetic.